Atopic dermatitis (AD) is a complex disease with a firmly established genetic underpinning. Altered skin colonization by Staphylococcus aureus is common in AD and is associated with disease severity, but not all AD patients are colonized. Keratinocytes, which constitute 85% of the cells of the epidermis, the first line of defense in the skin, play a central role in AD pathogenesis. Increased susceptibility to infections and cutaneous colonization suggest immune dysregulation and skin barrier dysfunction where genetic variation is very likely to play a role. Genes in these pathways have been implicated by genome wide association studies (GWAS) of AD, but genetic studies focusing specifically on S. aureus colonization have yet to be performed. A cost- effective strategy to boost power in genetic association studies is to sequence a portion of a population and generate ?synthetic? genomes for the remaining samples by imputing the sequence data to the rest of the dataset genotyped on a genome-wide marker array. Through the NIAID-supported Atopic Dermatitis Research Network (ADRN), we have already completed whole genome sequencing (WGS) on 500 ADRN participants with/without persistent S. aureus colonization. As with other studies, most significant GWAS markers lie in intergenic or intronic regions, which may reflect regulatory variants. Expression quantitative trait loci (eQTL) represent one strategy to test if genome-wide marker panels can explain expression in the transcriptome, and control of gene expression is one way genetic variants might control risk to AD. The skin microbiota resists pathogens and educates the immune system, and the epidermis mediates this interface. We hypothesize interactions between the human host and symbiotic bacteria, when disrupted by genetic or environmental changes, can result in persistent S. aureus colonization among AD patients. To test this hypothesis, we will integrate one of the most comprehensive databases on S. aureus colonization among AD patients using RNA- Seq and eQTL mapping to elucidate genetic variation underpinning differences in levels of gene expression in the AD epidermis.
Our specific aims i nclude: (i) combine WGS data with genome-wide marker data to identify genetic variants influencing risk of S. aureus colonization and disease severity in 1,100 colonized and uncolonized AD patients; (ii) identify cis- and trans-effects of variants in the epidermis transcriptome of AD patients with S. aureus colonization by eQTL mapping; and (iii) examine the complex relationships between the host epithelial cell genome, the epidermal transcriptome and the functionally profiled microbiome to characterize the human-commensal interaction in S. aureus colonization of AD. We will also determine whether genetic and/or genomic (eQTL) determinants contribute to success of two clinical trials in this U19 application: (i) the microbiome transplant to decrease S. aureus colonization in AD (Microbiome Transplant protocol); and (ii) the dupilumab-induced reduction in S. aureus quantity (Dupilumab protocol). These studies will substantially advance our understanding of the molecular basis for S. aureus colonization and AD severity.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Program--Cooperative Agreements (U19)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Jewish Health
United States
Zip Code
Williams, Michael R; Nakatsuji, Teruaki; Sanford, James A et al. (2017) Staphylococcus aureus Induces Increased Serine Protease Activity in Keratinocytes. J Invest Dermatol 137:377-384
Nakatsuji, Teruaki; Chen, Tiffany H; Narala, Saisindhu et al. (2017) Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med 9:
Liu, Haiyun; Archer, Nathan K; Dillen, Carly A et al. (2017) Staphylococcus aureus Epicutaneous Exposure Drives Skin Inflammation via IL-36-Mediated T Cell Responses. Cell Host Microbe 22:653-666.e5
Oyoshi, Michiko K; Venturelli, Nicholas; Geha, Raif S (2016) Thymic stromal lymphopoietin and IL-33 promote skin inflammation and vaccinia virus replication in a mouse model of atopic dermatitis. J Allergy Clin Immunol 138:283-6
Shi, Baochen; Bangayan, Nathanael J; Curd, Emily et al. (2016) The skin microbiome is different in pediatric versus adult atopic dermatitis. J Allergy Clin Immunol 138:1233-1236
Leung, Donald Y M (2016) Clinical implications of new mechanistic insights into atopic dermatitis. Curr Opin Pediatr 28:456-62
Galand, Claire; Leyva-Castillo, Juan Manuel; Yoon, Juhan et al. (2016) IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells. J Allergy Clin Immunol 138:1356-1366
Malhotra, Nidhi; Yoon, Juhan; Leyva-Castillo, Juan Manuel et al. (2016) IL-22 derived from ?? T cells restricts Staphylococcus aureus infection of mechanically injured skin. J Allergy Clin Immunol 138:1098-1107.e3
Gallo, Richard L; Hultsch, Thomas; Farnaes, Lauge (2016) Recognizing that the microbiome is part of the human immune system will advance treatment of both cancer and infections. J Am Acad Dermatol 74:772-4
Li, Shan; Ganguli-Indra, Gitali; Indra, Arup K (2016) Lipidomic analysis of epidermal lipids: a tool to predict progression of inflammatory skin disease in humans. Expert Rev Proteomics 13:451-6

Showing the most recent 10 out of 24 publications